Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice

Clinical trials of oncolytic virotherapy have shown low toxicity and encouraging signs of efficacy. However, it remains critically important to develop methods for systemic viral delivery if such therapies are to be clinically implemented to treat established tumors. In this respect, much effort is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kottke, Timothy, Hall, Geoff, Pulido, Jose, Diaz, Rosa Maria, Thompson, Jill, Chong, Heung, Selby, Peter, Coffey, Matt, Pandha, Hardev, Chester, John, Melcher, Alan, Harrington, Kevin, Vile, Richard
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2010
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2860921/
https://ncbi.nlm.nih.gov/pubmed/20364090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI41431
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados